Publications

5674 Results

Significant impact of HLA class I allele expression on outcome in melanoma patients treated with an allogeneic melanoma cell lysate vaccine. Final analysis of SWOG-9035.

Authors
VK Sondak;J Sosman;JM Unger;PY Liu;J Thompson;R Tuthill;R Kempf;L Flaherty
Journal / Conference
Proc of the American Society of Clinical Oncology 23:707 (#7501)
Year
2004
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9035

Predictors of vitality (energy/fatigue) in early stage hodgkin's disease (HD): results from Southwest Oncology Group (SWOG) study 9133

Authors
PA Ganz;CM Moinpour;S McCoy;DK Pauler;OW Press;RI Fisher
Journal / Conference
Proc of the American Society of Clinical Oncology 23:567 (#6546)
Year
2004
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9208

EGFr dinucleotide repeat polymorphism in non-small cell lung cancer

Authors
S Dubey;J Miller;P Stephenson;SM Keller;DH Johnson;JH Schiller;JM Kolesar
Journal / Conference
Proc of the American Society of Clincial Oncology 23:852 (#9585)
Year
2004
Research Committee(s)
Lung
Study Number(s)
SWOG-9252 (INT-0115) (EST-3590) (RTOG 91-05) (NCCTG-91-24-51) (CALGB-9393)

An intergroup randomized controlled clinical trial (RCT) of chemotherapy plus radiation (RT) versus RT alone for pure and mixed anaplastic oligodendrogliomas: initial report of RTOG 94-02

Authors
G Cairncross;W Seiferheld;E Shaw;R Jenkins;B Scheithauer;D Brachman;J Buckner;K Fink;L Souhami;W Curran
Journal / Conference
Proc of the American Society of Clinical Oncology 23:107 (#1500)
Year
2004
Research Committee(s)
Brain
Study Number(s)
SWOG-9402

Japan-SWOG common arm analysis of paclitaxel/carboplatin in advanced stage non-small cell lung cancer (NSCLC): a model for prospective comparison of cooperative group trials

Authors
DR Gandara;Y Ohe;K Kubota;Y Nishiwaki;Y Ariyoshi;N Saijo;S Williamson;PN Lara;J Crowley;M Fukuoka
Journal / Conference
Proc of the American Society of Clinical Oncology 23:616 (#7007)
Year
2004
Research Committee(s)
Lung
Study Number(s)
S0003

Interferon Alpha-2b and thalidomide in previously treated patients with disseminated malignant melanoma: SWOG 0026

Authors
L Hutchins;J Moon;J Clark;J Thompson;K Yost;V Sondak
Journal / Conference
Proc of the American Society of Clinical Oncology 23:713 (#7527)
Year
2004
Research Committee(s)
Melanoma
Study Number(s)
S0026

A phase II evaluation of a 3-hour infusion of paclitaxel (P), cisplatin (CDDP) & 5-fluorouracil (5FU) in patients with advanced or recurrent squamous cell carcinoma of the head and neck (SCCHN). A Southwest Oncology Group (SWOG) study

Authors
FP Worden;J Moon;W Samlowski;J Clark;SR Dakhil;SA Taylor;SG Urba;M Hussain
Journal / Conference
Proc of the American Society of Clinial Oncology 23:489 (#5512)
Year
2004
Research Committee(s)
Head and Neck
Study Number(s)
S0007

Sequential vinorelbine (V) and docetaxel (D) in advanced non-small cell lung cancer (NSCLC) patients age > 70, or with performance status (PS) 2: a SWOG phase II trial (S0027)

Authors
PJ Hesketh;K Chansky;DH Lau;J Crowley;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology 23:627 (#7056)
Year
2004
Research Committee(s)
Lung
Study Number(s)
S0027

Dose effect of imatinib (IM) in patients (pts) with metastatic GIST-phase III sarcoma group study S0033

Authors
C Rankin;M von Mehren;C Blanke;R Benjamin;CDM Fletcher;V Bramwell;J Crowley;GD Demetri
Journal / Conference
Proc of the American Society of Clinical Oncology 23:815 (#9005)
Year
2004
Research Committee(s)
Sarcoma
Study Number(s)
S0033

A phase II trial of epothilone B analogue BMS-247550 (NSC# 710428) in patients with advanced pancreas cancer: a Southwest Oncology Group study

Authors
RP Whitehead;SA McCoy;SE Rivkin;HM Gross;ME Conrad;JL Abbruzzese
Journal / Conference
Proc of the American Society of Clinical Oncology 23:315 (4012)
Year
2004
Research Committee(s)
Gastrointestinal
Study Number(s)
S0107